RxDoctor Payments Data

Brandi Harper, APRN

Family · Clemson, SCNPI 1124796743

Payments from drug & device makers

$851in general payments, 2019–2025

Across 48 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$139
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$104
  • Bayer$91
  • Amgen$86
  • Novo Nordisk$73
  • Exact Sciences$58
  • plus $300 from 11 others

What the payments were for

  • Food & beverage$851100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$851 in reported general payments places this provider in the 60th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$43,652
Medicare patients
201
Services billed
865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$23,173
XareltoRivaroxaban12$15,558
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$12,960
Diclofenac Sodium32$1,591
Celecoxib17$959
Albuterol Sulfate HfaAlbuterol Sulfate19$931
Ezetimibe36$880
Gabapentin44$819
Montelukast Sodium55$687
Duloxetine Hcl17$646
Famotidine49$622
Rosuvastatin Calcium83$620
Omeprazole48$519
Atorvastatin Calcium69$490
Metoprolol Succinate45$471

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$73$23,17318 claims
GSKTrelegy Ellipta$139$12,96011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,248 family providers in South Carolina.

Other family in Clemson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →